Sandbox:lipid: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 112: | Line 112: | ||
|Reduce procedure time and contrast load by reducing number of periprocedural root | |Reduce procedure time and contrast load by reducing number of periprocedural root | ||
injections | injections | ||
|} | |||
{| class="wikitable" | |||
! colspan="2" |TAVR Procedural Complications and Management | |||
|- | |||
!Complication | |||
!Treatment Options | |||
|- | |||
|Valve embolization | |||
* Aortic | |||
* Left ventricle | |||
| | |||
* Recapture or deploy in descending aorta if still attached to delivery system (self-expanding) | |||
* Valve-in-valve | |||
* Endovascular (snare) | |||
* SAVR and extraction | |||
|- | |||
|Central valvular aortic regurgitation | |||
| | |||
* Usually self-limited, but may require gentle probing of leaflets with a soft wire or catheter | |||
* Delivery of a second TAVR device | |||
|- | |||
|Paravalvular aortic regurgitation | |||
| | |||
* Post-deployment balloon dilation | |||
* Delivery of a second TAVR device Repositioning of valve if low (recapture, snare) | |||
* Percutaneous vascular closure devices (e.g., Amplatzer Vascular Plug) | |||
* SAVR | |||
|- | |||
|Shock or hemodynamic collapse | |||
| | |||
* Assess and treat underlying cause if feasible | |||
* Inotropic support | |||
* Mechanical circulatory support | |||
* CPB | |||
|- | |||
|Coronary occlusion | |||
| | |||
* PCI (easier if coronaries already wired before valve implantation) | |||
* CABG | |||
|- | |||
|Annular rupture | |||
| | |||
* Reverse anticoagulation | |||
* Surgical repair | |||
* Pericardial drainage | |||
|- | |||
|Ventricular perforation | |||
| | |||
* Reverse anticoagulation | |||
* Surgical repair | |||
* Pericardial drainage | |||
|- | |||
|Complete heart block | |||
|Transvenous pacing with conversion to PPM if needed | |||
|- | |||
|Stroke | |||
* Ischemic | |||
* Hemorrhagic | |||
| | |||
* Catheter-based, mechanical embolic retrieval for large ischemic CVA | |||
* Conservative | |||
|- | |||
|Bleeding/hemorrhage | |||
| | |||
* Treat source if feasible | |||
* Transfusion | |||
* Reversal of anticoagulation | |||
|- | |||
|Access site-related complications | |||
|Urgent endovascular or surgical repair | |||
|} | |} |
Latest revision as of 18:44, 16 January 2017
TAVR Imaging Evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR CT | ECHO | ||||||||||||||||||||||||||||||||||||||||||||||||||
Non-gated Angigram of Chest, Abdomen and Pelvic arteries for vascular access selection | ECG gated CT of annulus and Aortic root for valve sizing selection | Left ventricles and other findings | Confirm severe Aortic Stenosis | ||||||||||||||||||||||||||||||||||||||||||||||||
Transfemoral Approach | Annular sizing | Aortic Root sizing | Additional Procedural Planning | ||||||||||||||||||||||||||||||||||||||||||||||||
Subclavian Approach | Major/Minor Dimension | Coronary Ostia height | Fluoroscopy Angulation | LVEF and LV dimension | High gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Apical Approach | Area | Aortic Sinus to Commissure dimension | Bypass Grafts | Estimated Pulmonary pressure | Low gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Other Approaches | Circumferences | Sinotubular Junction | RV to Chest wall position | Other valvular abnormalities | Reduced EF | ||||||||||||||||||||||||||||||||||||||||||||||
Carotid | Ascending Aorta dimension | Preserved EF | |||||||||||||||||||||||||||||||||||||||||||||||||
Direct Aortic | Aortic Calcification | ||||||||||||||||||||||||||||||||||||||||||||||||||
Transvenous | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR CT Measurement Summary | |||
---|---|---|---|
Valve Size and Type | |||
Region of Interest | Specific
Measurements |
Measurement Technique | Additional
Comments |
Aortic valve morphology
and function |
Aortic valve |
|
Most useful in cases of LFLG AS where diagnosis is otherwise
unclear. May be helpful in defining number of valve cusps. |
LV geometry and other
cardiac findings |
LV outflow tract |
|
Quantification of calcification not standardized.
Large eccentric calcium may predispose for paravalvular regurgitation and annular rupture during valve deployment. |
Annular sizing | Aortic annulus |
|
Periprocedural TEE and/or balloon sizing can confirm
dimensions during case. |
Aortic root measurements | Sinus of Valsalva |
|
|
Coronary and thoracic
anatomy |
Coronary arteries |
|
Short coronary artery height increases risk of procedure.? Evaluation of coronary artery and bypass graft stenosis on select studies. Estimate risk of coronary occlusion during valve deployment. |
Aortic root
angulation |
|
Reduce procedure time and contrast load by reducing number of periprocedural root
injections |
TAVR Procedural Complications and Management | |
---|---|
Complication | Treatment Options |
Valve embolization
|
|
Central valvular aortic regurgitation |
|
Paravalvular aortic regurgitation |
|
Shock or hemodynamic collapse |
|
Coronary occlusion |
|
Annular rupture |
|
Ventricular perforation |
|
Complete heart block | Transvenous pacing with conversion to PPM if needed |
Stroke
|
|
Bleeding/hemorrhage |
|
Access site-related complications | Urgent endovascular or surgical repair |